Skip to search formSkip to main contentSkip to account menu

Insulin Aspart

Known as: B28asp, Insulin, Insulin, Aspartic Acid(B28)-, Insulin Aspart [Chemical/Ingredient] 
Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This study was carried out to investigate the effects of feeding a diet (Pediococcus acidilac ci), aflatoxin B1 and aflatoxin B1… 
2016
2016
U sing identif ication in the use medicine  with Beer 's C riteria to the advanced age patients in Inpatient installation in Ibnu… 
2015
2015
Di a b e t e s m a n a g e m e n t i s undergoing a paradigm shift in treatment approach that is more “patient-centred… 
2010
2010
Continuous subcutaneous insulin infusion (CSII) therapy is widely accepted for brittle type 1 diabetes, since it has the benefit… 
Review
2009
Review
2009
The insulin regimen of a Type 2 diabetic presenting for surgery had been changed recently from a 70/30 mixture of insulin aspart… 
2008
2008
Einleitung: Die SIT-Studie untersuchte zwei Konzepte zur Intensivierung eines unzureichend eingestellten Typ-2-Diabetes: eine… 
2007
2007
Despite the good intentions of the St. Vincent Declaration to reduce adverse outcomes down to that seen in nondiabetic pregnant… 
2004
2004
The human insulin analog aspart is produced by recombinant technology that replaces the proline at position 28 on the β-chain of… 
2003
2003
Como parte das atividades curriculares do 4° e 5° periodos da graduacao medica, a disciplina de Semiologia contempla visitas as… 
1999
1999
Insulin aspart is a recombinant analogue of human insulin. Following subcutaneous insulin injection (0.15 to 0.2 U/kg…